SigmaLabs

SigmaLabs is a Ramat Gan-based accelerator built for technically deep founders who want help reaching their first real product milestones without the friction that the more institutional accelerator programs introduce. The orientation is founder-friendly in the practical sense rather than the marketing sense.

The thesis is to back deep-technical teams across software, AI, and data-intensive products, with active acceptance of digital health and AI/ML in healthcare companies. The program is comfortable with the ambiguity of pre-product or very early-stage companies, and it tends to engage substantively with the technical substance of what founders are building rather than restricting itself to deck-level conversation. AI-native companies are a natural fit, and the program selects for founders whose moats live in the engineering rather than in distribution shortcuts that will not survive scaling.

Checks are below two hundred and fifty thousand dollars at the Pre-Seed and Seed stages, structured around an accelerator program rather than as standalone seed investments. Geography is anchored in Israel, with portfolio companies pointed at global markets, primarily the US and Europe. SigmaLabs is positioned as a first institutional check for technically credible teams who want a structured runway to get from prototype to product-market fit, and it expects founders to engage with the work of the program rather than treat it as a passive capital event.

The team runs the program with a hands-on cadence. Founders interact directly with the operating team, and the support is calibrated to actual stage rather than a generic curriculum. The diligence engages with technical and commercial questions in roughly equal measure, and the bias is toward founders who can demonstrate real engineering depth combined with at least an intuition for who the customer is and how to reach them.

In practice, the value-add concentrates on the parts of early-stage company building that founders coming out of technical roles most often underestimate. That includes positioning and ICP definition, early customer development, fundraising preparation for an institutional Seed, and the operational discipline of building a small team that does not break under early growth. SigmaLabs is direct about what it is. It is not a hardware-heavy program, it is not a therapeutics fund, and it is not a long-cycle deep-tech vehicle. For founders building software-driven AI and digital health companies who want a focused early-stage accelerator with real capital and substantive engagement, it is one of the more practical programs in the Israeli ecosystem. The conversations are grounded, the engagement is direct, and the founders who tend to get the most out of the program are those who treat it as a working partnership rather than a credentialing exercise.